Völz S, Redfors B, Angerås O, et al. - Researchers sought to compare two treatment approaches for managing patients experiencing heart failure due to ischaemic heart disease: coronary artery bypass grafting (CABG) vs percutaneous coronary intervention (PCI). In patients having heart failure with reduced ejection fraction and multivessel disease (coronary artery stenosis >50% in ≥2 vessels or left main) who had coronary angiography between 2000 and 2018 in Sweden, experts assessed all-cause mortality after CABG or PCI. This study involved 2,509 patients (82.9% men). PCI was the primary designated therapy in 56.2% and CABG was received by 43.8%. Findings revealed that a greater long-term survival in patients with ischaemic heart failure was evident following CABG vs after PCI.